Vandenbosch Betty M.
Known title: DirectorCIK: 0001852626
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Coursera Faces Hold Rating, Q3 Outlook Uncertain Amid AI Growth. Coursera was downgraded to Hold ahead of its Q3 earnings, as analysts await progress on a potential merger. A preview of the quarter suggests the stock could be a value trap until organic growth resumes. The company is also part of the AI retraining boom, but its price remains near the $5.30 support level.
Transaction History
| CVSA | ▼ Sell | Tax Withholding | 421 | $41K | 11/13/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 1,445 | $140K | 11/12/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 1,560 | $140K | 11/13/2024 | View on chart |
| COUR | ▼ Sell | Tax Withholding | 914 | $13K | 8/15/2022 | View on chart |
| COUR | ▼ Sell | Tax Withholding | 914 | $14K | 5/15/2022 | View on chart |
| COUR | ▲ Buy | Option Exercise | 15,000 | $119K | 4/5/2022 | View on chart |
| COUR | ▼ Sell | Open Market | 15,000 | $347K | 4/5/2022 | View on chart |
| COUR | ▲ Buy | Option Exercise | 9,615 | $58K | 3/18/2022 | View on chart |
| COUR | ▼ Sell | Open Market | 14,450 | $290K | 3/18/2022 | View on chart |
| COUR | ▲ Buy | Option Exercise | 4,835 | $38K | 3/18/2022 | View on chart |
| COUR | ▲ Buy | Option Exercise | 550 | $3K | 3/17/2022 | View on chart |
| COUR | ▼ Sell | Open Market | 550 | $11K | 3/17/2022 | View on chart |
| COUR | ▼ Sell | Tax Withholding | 605 | $13K | 2/15/2022 | View on chart |
| COUR | ▼ Sell | Open Market | 15,000 | $313K | 2/7/2022 | View on chart |
| COUR | ▲ Buy | Option Exercise | 15,000 | $91K | 2/7/2022 | View on chart |
| COUR | ▲ Buy | Option Exercise | 15,000 | $91K | 1/5/2022 | View on chart |
| COUR | ▼ Sell | Open Market | 8,214 | $200K | 1/5/2022 | View on chart |
| COUR | ▼ Sell | Open Market | 6,786 | $170K | 1/5/2022 | View on chart |
| COUR | ▲ Buy | Option Exercise | 35,000 | $212K | 12/31/2021 | View on chart |
| COUR | ▼ Sell | Open Market | 35,000 | $862K | 12/31/2021 | View on chart |
| COUR | ▲ Buy | Grant | 22,611 | $0 | 11/30/2021 | View on chart |
| COUR | ▼ Sell | Tax Withholding | 914 | $33K | 11/15/2021 | View on chart |
| COUR | ▲ Buy | Option Exercise | 25,000 | $152K | 10/29/2021 | View on chart |
| COUR | ▼ Sell | Open Market | 25,000 | $883K | 10/29/2021 | View on chart |
| COUR | ▲ Buy | Option Exercise | 25,000 | $152K | 10/28/2021 | View on chart |
| COUR | ▼ Sell | Open Market | 25,000 | $877K | 10/28/2021 | View on chart |
| COUR | ▲ Buy | Option Exercise | 8,334 | $51K | 8/30/2021 | View on chart |
| COUR | ▼ Sell | Open Market | 8,334 | $318K | 8/30/2021 | View on chart |
| COUR | ▼ Sell | Tax Withholding | 2,418 | $93K | 8/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Covista receives mixed analyst coverage and rating update
Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.
Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.